Clinicopathological Pattern Of Salivary Gland Tumors: A Decade’S Experience In Osogbo, Southwest Nigeria
African Journal of Oral Health · 2026
DOI: 10.67250/wsvee863 ↗Kurz gefasst
Fachartikel in der Zeitschrift African Journal of Oral Health, 2026. Verfasst von Abayomi OJO und 1 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Background
Salivary glands tumors occur worldwide, with substantive disease burden, across all age, sex and regions; however, it is poorly described in sub-Saharan Africa.
Objective
To describe the clinical and histopathologic spectrum of salivary gland tumors in a sub-urban Nigerian tertiary hospital.
Methods
This descriptive and retrospective study was conducted at the UNIOSUN Teaching Hospital (UTH), Osogbo, Nigeria. Patients with salivary gland tumors who had surgical excision and histological diagnosis from 2016 – 2025 were included. Records were retrieved from patient folders, surgical notes, theatre logbooks, and histopathology reports. Structured proforma was used to collect information. Descriptive statistics was used to analyse results.
Result
Of 820 head and neck tumor surgeries, 64 (7.8%) were in salivary gland. The mean age was 40.3 ± 18.4 years. with 35 (54.7%) males, and 29 (45.3%) females. Tumor site locations were parotid gland 31 (48.4%), submandibular 12 (18.8%), palate 8 (12.5%), and oropharynx 7 (10.9%). Benign tumors were 42 (65.6%), i.e., pleomorphic adenomas 39 (60.9%), and Warthin tumors 3 (4.7%). Malignant tumors were 22 (34.4%), mainly as adenoid cystic 13 (20.3%). Wide local excisions were done 41 (64.1%) and parotidectomies 23 (35.9%). General anaesthesia was used in 60 (93.8%), and local anaesthesia in 4 (6.3%). Recurrence was seen in 3 (4.7%).
Conclusion
Benign salivary gland tumors predominate in Nigeria, especially pleomorphic adenoma, while malignant tumors are less frequent. However, the low recurrence rate highlights the role of specialist review, accurate diagnosis and appropriate care to lower the disease burden 1. Lépine C. Tumeurs des glandes salivaires: OMS 2022 et au-delà [Salivary gland tumors: 2022 WHO blue book and beyond]. Ann Pathol. 2024;44(3):175-182. doi:10.1016/j.annpat.2024.02.005.
Zitieren
APA
OJO, A., & Adedeji, T. (2026). Clinicopathological Pattern Of Salivary Gland Tumors: A Decade’S Experience In Osogbo, Southwest Nigeria. African Journal of Oral Health. https://doi.org/10.67250/wsvee863
Vancouver
OJO A, Adedeji T. Clinicopathological Pattern Of Salivary Gland Tumors: A Decade’S Experience In Osogbo, Southwest Nigeria. African Journal of Oral Health. 2026. doi:10.67250/wsvee863
BibTeX
@article{OJO2026,
author = {OJO, Abayomi and Adedeji, Taiwo},
title = {Clinicopathological Pattern Of Salivary Gland Tumors: A Decade’S Experience In Osogbo, Southwest Nigeria},
journal = {African Journal of Oral Health},
year = {2026},
doi = {10.67250/wsvee863}
}
EUVIMED